|
|
||||||||
Department of Physiology, Medical School, and Institute for Medical Sciences, Jeonbug National University, Jeonju 561-180, Republic of Korea
The purpose of the present experiments was to define the role of C-type natriuretic peptide (CNP) in the regulation of atrial secretion of atrial natriuretic peptide (ANP) and atrial stroke volume. Experiments were performed in perfused beating and nonbeating quiescent atria, single atrial myocytes, and atrial membranes. CNP suppressed in a dose-related fashion the increase in atrial stroke volume and ANP secretion induced by atrial pacing. CNP caused a right shift in the positive relationships between changes in the secretion of ANP and atrial stroke volume or translocation of the extracellular fluid (ECF), which indicates the suppression of atrial myocytic release of ANP into the paracellular space. The effects of CNP on the secretion and contraction were mimicked by 8-bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP). CNP increased cGMP production in the perfused atria, and the effects of CNP on the secretion of ANP and atrial dynamics were accentuated by pretreatment with an inhibitor of cGMP phosphodiesterase, zaprinast. An inhibitor of the biological natriuretic peptide receptor (NPR), HS-142-1, attenuated the effects of CNP. The suppression of ANP secretion by CNP and 8-BrcGMP was abolished by a depletion of extracellular Ca2+ in nonbeating atria. Natriuretic peptides increased cGMP production in atrial membranes with a rank order of potency of CNP > BNP > ANP, and the effect was inhibited by HS-142-1. CNP and 8-BrcGMP increased intracellular Ca2+ concentration transients in single atrial myocytes, and mRNAs for CNP and NPR-B were expressed in the rabbit atrium. From these results we conclude that atrial ANP release and stroke volume are controlled by CNP via NPR-B-cGMP mediated signaling, which may in turn act via regulation of intracellular Ca2+.
atrial natriuretic peptide; guanosine 3',5'-cyclic monophosphate; guanylyl cyclase; calcium; natriuretic peptide receptor
This article has been cited by other articles:
![]() |
D. A. Heaton, M. Lei, D. Li, S. Golding, T. A. Dawson, R. M. Mohan, and D. J. Paterson Remodeling of the Cardiac Pacemaker L-Type Calcium Current and Its {beta}-Adrenergic Responsiveness in Hypertension After Neuronal NO Synthase Gene Transfer Hypertension, September 1, 2006; 48(3): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Dietz Mechanisms of atrial natriuretic peptide secretion from the atrium Cardiovasc Res, October 1, 2005; 68(1): 8 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Han, C. Cao, S. M. Kim, F. L. Piao, and S. H. Kim Attenuation of Lysophosphatidylcholine-Induced Suppression of ANP Release From Hypertrophied Atria Hypertension, February 1, 2004; 43(2): 243 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lee, S. Y. Kim, J. H. Han, Y. A. Kim, C. Cao, S. Z. Kim, K. W. Cho, and S. H. Kim Different Responses of Atrial Natriuretic Peptide Secretion and Its Receptor Density to Salt Intake in Rats Experimental Biology and Medicine, January 1, 2004; 229(1): 65 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rose, A. E. Lomax, and W. R. Giles Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2454 - H2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, J. F. Wen, J. Y. Jin, H. Jin, H. S. Ann, S. Z. Kim, S. H. Kim, H. S. Lee, and K. W. Cho Histamine inhibits atrial myocytic ANP release via H2 receptor-cAMP-protein kinase signaling Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R380 - R393. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cao, J. H. Han, S. Z. Kim, K. W. Cho, and S. H. Kim Diverse regulation of atrial natriuretic peptide secretion by serotonin receptor subtypes Cardiovasc Res, August 1, 2003; 59(2): 360 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Han, C. Cao, S. Z. Kim, K. W. Cho, and S. H. Kim Decreases in ANP Secretion by Lysophosphatidylcholine Through Protein Kinase C Hypertension, June 1, 2003; 41(6): 1380 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Seul, J. H. Han, K. Y. Kang, S. Z. Kim, and S. H. Kim Regulation of ANP secretion by cardiac Na+/Ca2+ exchanger using a new controlled atrial model Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R31 - R40. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, J. H. Han, C. Cao, S. Z. Kim, and K. W. Cho Postnatal changes in inhibitory effect of C-type natriuretic peptide on secretion of ANP Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1672 - R1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, J. F. Wen, J. Y. Jin, W. X. Xu, S. Z. Kim, S. H. Kim, H. S. Lee, and K. W. Cho Protein kinase-dependent and Ca2+-independent cAMP inhibition of ANP release in beating rabbit atria Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1477 - R1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Herring, J. A. B. Zaman, and D. J. Paterson Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2318 - H2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, J. H. Han, S. H. Lim, S. J. Lee, S. Z. Kim, and K. W. Cho Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1456 - R1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Wen, X. Cui, J. S. Ahn, S. H. Kim, K. H. Seul, S. Z. Kim, Y. K. Park, H. S. Lee, and K. W. Cho Distinct roles for L- and T-type Ca2+ channels in regulation of atrial ANP release Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2879 - H2888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |